Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-003016
Filing Date
2026-01-12
Accepted
2026-01-12 21:58:06
Documents
1
Period of Report
2026-01-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm263003-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm263003-1_4seq1.xml 4 12204
  Complete submission text file 0001104659-26-003016.txt   13808
Mailing Address 3052 PACIFIC AVENUE SAN FRANCISCO CA 94115
Business Address
Tananbaum James B. (Reporting) CIK: 0001581754 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42143 | Film No.: 26528306

Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Issuer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)